Safety, Tolerability, and Serum/Tear Pharmacokinetics of Human Recombinant Epidermal Growth Factor Eyedrops in Healthy Subjects

The purpose of this study was to evaluate the safety, tolerability, and pharmacokinetics (PKs) of rhEGF eyedrops after the administration of single and multiple doses in healthy subjects. A phase 1, randomized, double-blind, placebo-controlled, and single-ascending dose (SAD) and multiple-ascending...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Hyounggyoon, Yoon, Seonghae, Jang, In-Jin, Yu, Kyung-Sang, Hyon, Joon Young, Hwang, Jungi, Hwang, Inyoung, Sunwoo, Jung, Chung, Jae-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697941/
https://www.ncbi.nlm.nih.gov/pubmed/36355484
http://dx.doi.org/10.3390/ph15111312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697941/
https://www.ncbi.nlm.nih.gov/pubmed/36355484
http://dx.doi.org/10.3390/ph15111312

Ejemplares similares